Work

Non-epileptic myoclonus in Angelman syndrome

Year: 2026

Type: article

Abstract: No direct evidence for optimal treatment of non-epileptic myoclonus in Angelman syndrome was identified. Observational reports suggest potential benefits from perampanel, reserpine, clonazepam, and cannabidiol, yet further research is necessary to validate these findings.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.24021276

Author: Tripdatabase

Language: English

Topic: Epilepsy research and treatment

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7225429447

FWCI:

Cites:

Cited by:

Related to: 10